Tag: Sequentify

[Sequentify in PR Newswire] Sequentify collaborates with Yeda, the commercial arm of the Weizmann Institute, under an NIH grant for evaluating the effect of clonal hematopoiesis on cognitive impairment and kidney function decline

REHOVOT, Israel, Oct. 31, 2022 /PRNewswire/ — Sequentify announced its collaboration with Yeda, the commercial arm of the Weizmann Institute of Science (WIS) and NIH, as part of a grant to sequence over 6,000 patients using the Sequentify Myeloid NGS panel, offering cost-effective, high throughput NGS sequencing at scale. Read more...

Read More

[Sequentify in PR Newswire] Democratizing genomics, Sequentify raises $7M to enable DNA sequencing at scale

REHOVOT, Israel, May 10, 2022 /PRNewswire/ — Sequentify, a Weizmann Institute of Science spinoff, enables fast and focused DNA sequencing. It combines tools from the synthetic biology and AI software fields to enable rapid targeted DNA sequencing. Sequentify exits stealth mode with $7M in raised funds led by Israel’s most active venture firm, OurCrowd. The funds will be used to accelerate R&D, delivery, and go-to-market plans for the company. Read more...

Read More

Latest from Twitter